CD4 and colitis: We found that treating the CD4-Cre+/TgMettl14FL/FL conditional knockout mice with ciprofloxacin + metronidazole prevented the development of colitis phenotype as assessed by normal colonic weight-to-length ratio (Figure 7A) and eliminated inflammatory cell infiltration (Figure 7B).